Clinical Trials Browser

Phase NA × copper dotatate CU-64 × Endocrine × Clear all

NCT02125474 2019-11-14

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Phase NA Completed

Neuroendocrine Tumors